During the past decade, Kokkola Central Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kokkola Central Hospital" are "Acute Coronary Syndrome" (1 trials), "Acute Myocardial Infarction" (1 trials), "Atherosclerosis" (1 trials), "Myocardial Infarction" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "Kokkola Central Hospital" in a lesser frequency.

Most popular intervention types in "Kokkola Central Hospital" are "Procedure" (2 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Selatogrel" (1 trials), "Stenting using Optimax™" (1 trials), "Stenting using PROMUS Element™ Plus" (1 trials) and "Tonsillectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kokkola Central Hospital" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kokkola Central Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Kokkola Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kokkola Central Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".